The Effect of Very-Long-Chain n -3 Polyunsaturated Fatty Acids in the Central Nervous System and Their Potential Benefits for Treating Alcohol Use Disorder: Reviewing Pre-Clinical and Clinical Data.

Autor: Carvajal F; Department of Psychology, University of Almeria, 04120 Almeria, Spain.; Health Research Center, University of Almeria, 04120 Almeria, Spain., Sánchez-Gil A; Department of Psychology, University of Almeria, 04120 Almeria, Spain.; Health Research Center, University of Almeria, 04120 Almeria, Spain., Cardona D; Health Research Center, University of Almeria, 04120 Almeria, Spain.; Department of Nursing, Physiotherapy and Medicine, University of Almeria, 04120 Almeria, Spain., Rincón-Cervera MA; Food Technology Division, ceiA3, CIAMBITAL, University of Almeria, 04120 Almeria, Spain.; Institute of Nutrition and Food Technology, University of Chile, Santiago 830490, Chile., Lerma-Cabrera JM; Department of Psychology, University of Almeria, 04120 Almeria, Spain.; Health Research Center, University of Almeria, 04120 Almeria, Spain.
Jazyk: angličtina
Zdroj: Nutrients [Nutrients] 2023 Jun 30; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 30.
DOI: 10.3390/nu15132993
Abstrakt: Alcohol use poses a significant global health concern, leading to serious physical and socioeconomic issues worldwide. The current treatment options for problematic alcohol consumption are limited, leading to the exploration of alternative approaches, such as nutraceuticals. One promising target is very-long-chain n -3 polyunsaturated fatty acids (VLC n -3 PUFAs). This review aims to compile the most relevant pre-clinical and clinical evidence on the effect of VLC n -3 PUFAs on alcohol use disorders and related outcomes. The findings suggest that VLC n -3 PUFAs may alleviate the physiological changes induced by alcohol consumption, including neuroinflammation and neurotransmitter dysregulation. Additionally, they can reduce withdrawal symptoms, improve mood, and reduce stress level, all of which are closely associated with problematic alcohol consumption. However, more research is required to fully understand the precise mechanisms by which VLC n -3 PUFAs exert their function. Furthermore, PUFAs should not be considered a standalone solution, but as a complement to other therapeutic approaches. Although preliminary evidence supports the potential therapeutic effect of VLC n -3 PUFAs on problematic alcohol consumption, additional research is needed to validate these findings and determine the optimal use of PUFAs as part of a comprehensive approach to the treatment of alcohol use disorders.
Databáze: MEDLINE